Improvement in 1-in-4 patients with less multimorbidity or ≤8 meds
Strong evidence that interventions focused on limited problems work
Need holistic measure reflecting patient perspectives
Quality of life
Broad reaching
May be insensitive to changes achieved through med review
Rupert reflects on possible reasons that IMPP did "not work" with important points about medicines related research in general. Issues such as #polypharmacy are necessarily complicated to research. It can also be hard to work out what the right outcome measures are. #SWPRN25